Bayer reports phase I results for prostate cancer therapy
Go back to Bayer reports phase I results for prostate cancer therapy| Bay National Corporation (AMEX: BAYN) | Delayed: 0.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.01 | 52 Week High | $0.04 | |||
| Open | $61.11 | 52 Week Low | $0.03 | |||
| Day High | $0.01 | P/E | 0.00 | |||
| Day Low | $0.01 | EPS | $-8.34 | |||
| Volume | 358,028 | |||||
| Bayer Aktiengesellschaft American Depositary Shares (AMEX: BAYRY) | Delayed: 14.28 -0.16 (1.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.44 | 52 Week High | $135.54 | |||
| Open | $14.35 | 52 Week Low | $94.36 | |||
| Day High | $14.35 | P/E | N/A | |||
| Day Low | $14.22 | EPS | $0.00 | |||
| Volume | 310,474 | |||||
| Bayer AG (AMEX: BAYZF) | Delayed: 56.90 -0.9 (1.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $57.80 | 52 Week High | $135.00 | |||
| Open | $56.90 | 52 Week Low | $94.95 | |||
| Day High | $57.07 | P/E | N/A | |||
| Day Low | $56.90 | EPS | $0.00 | |||
| Volume | 509 | |||||

